Immune Checkpoint Inhibitor–Related Myocarditis With or Without Concomitant Myopathy

Patients with irMyocarditis and irMyopathy and those with isolated irMyocarditis have distinct biomarker profiles and cardiovascular complications. These differences should be confirmed in larger prospective cohorts to guide tailored management strategies.

Authors

Institutions

Publication Details

Journal
JACC CardioOncology
Published
2025-03-17
DOI
https://doi.org/10.1016/j.jaccao.2025.02.005
Citations
7
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
7.32
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immune Checkpoint Inhibitor–Related Myocarditis With or Without Concomitant Myopathy

Anju Nohria, Osnat Itzhaki Ben Zadok, Méabh O’Hare
7 citations
JACC CardioOncology
Cancer Immunotherapy and Biomarkers
7.32
article

Immune Checkpoint Inhibitor–Related Myocarditis With or Without Concomitant Myopathy

Anju Nohria, Osnat Itzhaki Ben Zadok, Méabh O’Hare
article en
7 citations

Abstract

Patients with irMyocarditis and irMyopathy and those with isolated irMyocarditis have distinct biomarker profiles and cardiovascular complications. These differences should be confirmed in larger prospective cohorts to guide tailored management strategies.

JACC CardioOncologyVol. 7(3)
Brigham and Women's Hospital (US), Tel Aviv University (IL)
Zero hunger
Openalex Percentile: Top 3%
Cancer Immunotherapy and Biomarkers
7.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.